Cross-publisher agreement on the defining principles of plain language summaries of publications (PLSPs)

Introduced in 2020, plain language summaries of publications (PLSPs) are standalone articles that aim to expand the reach of scientific findings to non-specialist audiences using plain language and meaningful visuals. Despite increased publication, there is no agreed cross-publisher definition of PLSPs, resulting in inconsistent terminology, formatting, peer-review processes, and metadata that hinder indexing and discoverability in bibliographic databases such as PubMed and Europe PMC. In February 2024, the multistakeholder collaboration Open Pharma launched an initiative to review existing standards and practices related to the publication of PLSPs. After identifying three publishers offering standalone PLSPs - Becaris Publishing, Sage, and Taylor & Francis - representatives from each formed a steering committee to define PLSPs and agree on principles that differentiate them from other publishing formats. PLSPs are defined as standalone summaries of peer-reviewed articles, written according to plain language principles, published open access with a unique digital object identifier (DOI), and are themselves peer reviewed (including by someone who is not a scientific specialist in the topic area). They should include a summary, clear reference to the original article, and a combination of text and meaningful graphics. This consensus provides a foundation for standardizing PLSPs as a distinct article type and acceptable secondary publication format. We hope it will also support consistent authoring, editorial management, peer-review processes and indexing. We call on indexing services to formally recognize PLSPs and on publishers to adopt this format as an accurate and reliable source of understandable scientific information.

Authors

Institutions

Publication Details

Journal
Current Medical Research and Opinion
Published
2026-07-16
DOI
https://doi.org/10.1080/03007995.2026.2700975
Primary Topic
Academic Publishing and Open Access
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cross-publisher agreement on the defining principles of plain language summaries of publications (PLSPs)

Kelly Soldavin, Laura Dormer, V Sanders, H. McDougall et al.
Current Medical Research and Opinion
Academic Publishing and Open Access
article

Cross-publisher agreement on the defining principles of plain language summaries of publications (PLSPs)

Kelly Soldavin, Laura Dormer, V Sanders, H. McDougall, Rachel Jenkins, Joanne Walker, Sophie Nobes
article en

Abstract

Introduced in 2020, plain language summaries of publications (PLSPs) are standalone articles that aim to expand the reach of scientific findings to non-specialist audiences using plain language and meaningful visuals. Despite increased publication, there is no agreed cross-publisher definition of PLSPs, resulting in inconsistent terminology, formatting, peer-review processes, and metadata that hinder indexing and discoverability in bibliographic databases such as PubMed and Europe PMC. In February 2024, the multistakeholder collaboration Open Pharma launched an initiative to review existing standards and practices related to the publication of PLSPs. After identifying three publishers offering standalone PLSPs - Becaris Publishing, Sage, and Taylor & Francis - representatives from each formed a steering committee to define PLSPs and agree on principles that differentiate them from other publishing formats. PLSPs are defined as standalone summaries of peer-reviewed articles, written according to plain language principles, published open access with a unique digital object identifier (DOI), and are themselves peer reviewed (including by someone who is not a scientific specialist in the topic area). They should include a summary, clear reference to the original article, and a combination of text and meaningful graphics. This consensus provides a foundation for standardizing PLSPs as a distinct article type and acceptable secondary publication format. We hope it will also support consistent authoring, editorial management, peer-review processes and indexing. We call on indexing services to formally recognize PLSPs and on publishers to adopt this format as an accurate and reliable source of understandable scientific information.

Current Medical Research and Opinion
Health & Medical Publishing Group (ZA), Taylor and Francis (United Kingdom)
Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, GlaxoSmithKline, Gilead Sciences, RTI International, Janssen Scientific Affairs, King's College London, Novo Nordisk, Astellas Pharma, Ipsen, Novartis Pharma, Kite Pharma
Partnerships for the goals
Openalex Percentile: Top 4%
Academic Publishing and Open Access
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.